checkAd

     180  0 Kommentare Victory Square Technologies Receives Approval for Sale & Distribution of VS SARS CoV-2 Antigen 15 Minute Nasal Rapid Test for Entire European Union  - Seite 2

    With this announcement, the Company has now received CE EU approvals for its three Covid-19 testing products including: 15 Minute Rapid Antibody Blood Test, ELISA Lab-based test, and today’s announced 15 minute Nasal Rapid Antigen Test. These product offerings now cover the essential testing procedures to detect SARS Covid-19 both at laboratory and at a point of care level.

    According to the European Centre for Disease Prevention and Control E-CDC “Rapid Antigen Test can contribute to overall COVID-19 testing capacity, offering advantages in terms of shorter turnaround times and reduced costs, especially in situations in which RT-PCR testing capacity is limited.” Reference: www.ecdc.europa.eu/ 

    This Safetest Covid-19 Rapid Test approval allows Victory Square Technologies to distribute throughout the following 27 EU & EEA countries with a combined population of 446,824,564:

    • Austria, Belgium, Bulgaria, Croatia, Republic of Cyprus, Czech, Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, Netherlands, Poland, Portugal, Romania, Slovakia, Slovenia, Spain, Sweden

    Victory Square also announces that it has engaged Proactive to provide written and video interview coverage of news releases and other corporate developments. Proactive is a financial news and events management company with bureaus in Vancouver, Toronto, New York, London, Sydney and Perth. Across all business lines, its worldwide client base numbers approximately 800 companies. Under the agreement, Proactive will provide coverage to Victory Square for a period of 12 months, at a total cost of $25,000.

    Disclaimer:

    The Company is not making any express or implied claims that its product has the ability to eliminate, cure or contain the Covid-19 (or SARS-2 Coronavirus) at this time

    Check out VictorySquare.com and sign up to VST’s official newsletter at www.VictorySquare.com/newsletter

    On behalf of the board,

    Shafin Diamond Tejani

    Chief Executive Officer

    Victory Square Technologies

    For further information about the Company, please contact:

    Investor Relations Contact – Alex Tzilios

    Email: alexandros@victorysquare.com

    Telephone: 778-867-0482

    Media Relations Contact – Howard Blank, Director

    Email: howard@victorysquare.com

    Telephone: 604-928-6066

    ABOUT VICTORY SQUARE TECHNOLOGIES INC.

    Victory Square (VST) builds, acquires and invests in promising startups, then provides the senior leadership and resources needed to fast-track growth.

    Seite 2 von 4


    Diskutieren Sie über die enthaltenen Werte


    globenewswire
    0 Follower
    Autor folgen

    Verfasst von globenewswire
    Victory Square Technologies Receives Approval for Sale & Distribution of VS SARS CoV-2 Antigen 15 Minute Nasal Rapid Test for Entire European Union  - Seite 2 Victory Square Technologies received the CE designation from the European Union (EU) competent authority of Belgium for VS SARS CoV-2 Antigen Rapid 15 Minute test on December 18th, 2020.The Company’s VS SARS CoV-2 Antigen 15 Minute Nasal Rapid Test …